It potentially reduces atherosclerosis by enhancing hepatic lipase activity, yet can increase atherosclerotic risk by inhibiting lecithin-CH acyltransferase and interfering with hepatic CH uptake (28). This evidence concerns the gene C4B and atherosclerosis.